Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Explore which index funds have low turnover and how this characteristic can reduce tax drag, improving after-tax results for long-term investing.
27,549 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
As companies report, global grow 2026 earnings becomes a key lens on global demand, margins, and cash flow. This guid...
IonQ posted quarterly results that beat expectations, triggering a notable after-hours rally. Analysts warn the stock...
As March moves unfold, the stock market today is colored by big auto headlines. Ford’s recall news sent ripples throu...
Two powerhouse energy stocks could shape the next decade. This guide explains why NextEra Energy and GE Vernova fit a...
Sleep habits shape dollars and decisions. This article explains practical, money-smart ways to improve rest, backed b...
Abcellera's Q1 2026 earnings transcript provides key clues about the path to 2026. This guide breaks down revenue dri...
Capricor is at a crossroads as 2026 earnings season unfolds. This article breaks down what to look for in capricor (c...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
SpaceX IPO chatter has investors buzzing and critics worried. This piece breaks down why the hype could outpace reali...
OpenAI’s fresh developments could tilt the landscape for AI hardware suppliers. This guide explains what Broadcom sto...